Larson Financial Group’s Integra LifeSciences IART Stock Holding History

Larson Financial Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-628	Closed	-$13.8K	–	3387
2025 Q1	$13.8K	Hold	628	–	–	﹤0.01%	1512
2024 Q4	$14.2K	Buy	628 +6	+1%	+$131	﹤0.01%	1348
2024 Q3	$11.3K	Buy	+622	New	+$14.4K	﹤0.01%	1434
2023 Q2	–	Sell	-100	Closed	-$5.74K	–	1601
2023 Q1	$5.74K	Hold	100	–	–	﹤0.01%	1059
2022 Q4	$5.61K	Hold	100	–	–	﹤0.01%	1001
2022 Q3	$4K	Buy	+100	New	+$5.12K	﹤0.01%	994

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Larson Financial Group's IART Position: Q2 2025 in Review

Larson Financial Group sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 628 shares — an estimated $13.8K sold.

Larson Financial Group first reported a position in IART in Q3 2022 and held it in 6 quarters. The position peaked at $14.2K in Q4 2024. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

Larson Financial Group reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
Larson Financial Group sold 628 Integra LifeSciences shares in Q2 2025, an estimated $13.8K.
Larson Financial Group first reported a position in Integra LifeSciences in Q3 2022 and held it in 6 quarters.
Larson Financial Group's Integra LifeSciences position peaked at $14.2K in Q4 2024.
208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on Larson Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.